BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 13931274)

  • 1. Behaviour of factors II, VII, IX and X during long-term treatment with coumarin.
    LOELIGER EA; van der ESCH ; MATTERN MJ; den BRABANDER AS
    Thromb Diath Haemorrh; 1963 Apr; 9():74-89. PubMed ID: 13931274
    [No Abstract]   [Full Text] [Related]  

  • 2. SURVIVAL TIME OF PROTHROMBIN AND FACTORS VII, IX AND X AFTER COMPLETELY SYNTHESIS BLOCKING DOSES OF COUMARIN DERIVATIVES.
    HELLEMANS J; VORLAT M; VERSTRAETE M
    Br J Haematol; 1963 Oct; 9():506-12. PubMed ID: 14076133
    [No Abstract]   [Full Text] [Related]  

  • 3. EFFECT OF ORAL ANTICOAGULANTS ON FACTORS VII, IX, X, AND II.
    KAZMIER F; SPITTELL JA; THOMPSON JJ; OWEN CA
    Arch Intern Med; 1965 Jun; 115():667-73. PubMed ID: 14299436
    [No Abstract]   [Full Text] [Related]  

  • 4. DETERMINANTS OF THE CLOTTING FACTOR RESPONSE TO WARFARIN IN THE RAT.
    PYOERAELAE K
    Ann Med Exp Biol Fenn; 1965; 43():SUPPL 3:1-99. PubMed ID: 14342207
    [No Abstract]   [Full Text] [Related]  

  • 5. AN INVESTIGATION OF THE HEMORRHAGIC DIATHESIS IN PATIENTS RECEIVING COUMARIN AND INDANEDIONE ANTICOAGULANTS.
    BAUGH CW
    Can Med Assoc J; 1965 Jan; 92(3):116-20. PubMed ID: 14232183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A COMPARISON OF BISHYDROXYCOUMARIN AND WARFARIN SODIUM IN TERMS OF COAGULATION FACTOR CHANGES AND BLEEDING COMPLICATIONS.
    FREMONT RE; WIEDMAN M; LUBELL D
    Am J Med Sci; 1963 Sep; 246():265-76. PubMed ID: 14063743
    [No Abstract]   [Full Text] [Related]  

  • 7. NATURE OF PROTHROMBIN BIOSYNTHESIS: PREPROTHROMBINAEMIA IN VITAMIN K-DEFICIENCY.
    HEMKER HC; VELTKAMP JJ; HENSEN A; LOELIGER EA
    Nature; 1963 Nov; 200():589-90. PubMed ID: 14082242
    [No Abstract]   [Full Text] [Related]  

  • 8. Control of dicumarol therapy by means of a micromethod for the quantitative determination of plasma prothrombin and proconvertin.
    LUND E; DYGGVE H
    Acta Med Scand; 1954; 150(4):271-5. PubMed ID: 13217722
    [No Abstract]   [Full Text] [Related]  

  • 9. COUMARIN THERAPY. PROTHROMBIN ACTIVITY AFTER TERMINATION OF TREATMENT.
    REILLY EB; GOODMAN JR; WARNER GF
    Calif Med; 1963 Oct; 99(4):234-5. PubMed ID: 14051485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STUDIES ON PROCONVERTIN (FACTOR VII).V. BIOSYNTHESIS IN SUSPENSION CULTURES OF RAT LIVER CELLS.
    PRYDZ H
    Scand J Clin Lab Invest; 1964; 16():540-8. PubMed ID: 14209214
    [No Abstract]   [Full Text] [Related]  

  • 11. PROTHROMBIN LEVELS DURING THE FIRST YEAR OF LIFE. OBSERVATIONS FOLLOWED BY THE SYNTHETIC SUBSTRATE (TAME) ASSAY OF NORMAL FULL-TERM INFANTS.
    GLUECK HI; SUTHERLAND J; GLESER G
    Am J Dis Child; 1964 Jun; 107():612-7. PubMed ID: 14133821
    [No Abstract]   [Full Text] [Related]  

  • 12. Preparation of a human plasma fraction rich in prothrombin, proconvertin, Stuart factor, and PTC and a study of its activity and toxicity in rabbits and man.
    DIDISHEIM P; LOEB J; BLATRIX C; SOULIER JP
    J Lab Clin Med; 1959 Feb; 53(2):322-30. PubMed ID: 13621053
    [No Abstract]   [Full Text] [Related]  

  • 13. ["COAGULANT" FRACTIONS CONTAINING COAGULATION FACTORS ADSORBABLE BY TRICALCIC PHOSPHATE].
    SOULIER JP; BLATRIX C; STEINBUCH M
    Presse Med (1893); 1964 Apr; 72():1223-8. PubMed ID: 14134215
    [No Abstract]   [Full Text] [Related]  

  • 14. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin.
    OWREN PA; AAS K
    Scand J Clin Lab Invest; 1951; 3(3):201-8. PubMed ID: 14900966
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of synthetic vitamin K1 on prothrombin, factor VII complex and factor IX in premature infants].
    YOSHIDA K; MORII N; KANMI M; YOSHIDA K
    Paediatr Jpn; 1963 Jun; 67():373-8. PubMed ID: 14002672
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of nitro-- derivatives of warfarin on blood coagulation].
    Lakin KM; Smirnova TV; Karaseva MG; Fel'dbaum VA
    Farmakol Toksikol; 1967; 30(4):456-60. PubMed ID: 5598901
    [No Abstract]   [Full Text] [Related]  

  • 17. TURNOVER OF PROTHROMBIN AND FACTORS VII, IX AND X IN STATES OF HYPOCOAGULABILITY.
    HELLEMANS J; DEVREKER R; VORLAT M; VERSTRAETE M
    Acta Haematol; 1963 Jul; 30():35-41. PubMed ID: 14045902
    [No Abstract]   [Full Text] [Related]  

  • 18. ADMINISTRATION AND CONTROL OF ANTICOAGULANT TREATMENT.
    POLLER L
    Manch Med Gaz; 1964; 43():8-11. PubMed ID: 14125255
    [No Abstract]   [Full Text] [Related]  

  • 19. HAEMORRHAGIC DIATHESIS DUE TO CRIMINAL POISONING WITH WARFARIN.
    IKKALA E; MYLLYLAE G; NEVANLINNA HR; PELKONEN R; PYOERAELAE K
    Acta Med Scand; 1964 Aug; 176():201-3. PubMed ID: 14213888
    [No Abstract]   [Full Text] [Related]  

  • 20. STUDIES ON PROCONVERTIN (FACTOR VII) II. PURIFICATION.
    PRYDZ H
    Scand J Clin Lab Invest; 1964; 16():101-7. PubMed ID: 14124442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.